In today's world, Methylmethaqualone is a relevant topic that deserves our attention. Since its inception, Methylmethaqualone has captured the interest of millions of people around the world. Whether for its impact on society, its relevance in history, its possible consequences in the future, or simply for its ability to thrill and surprise, Methylmethaqualone remains a topic of great importance. In this article, we will explore the different aspects of Methylmethaqualone, delving into its origins, evolution, and possible implications. Join us on this journey to discover everything there is to know about Methylmethaqualone.
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C17H16N2O |
Molar mass | 264.328 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Methylmethaqualone (MMQ) is a quinazolinone and an analogue of methaqualone that has similar sedative and hypnotic properties to its parent compound (resulting from its agonist activity at the β subtype of the GABAA receptor) and is around 3 times as potent in animal models. Methylmethaqualone differs from methaqualone by 4-methylation on the phenyl ring. It was made illegal in Germany in 1999 and listed by the DEA as a "drug of forensic interest" at about the same time, but little other information is available. It would appear that this compound was sold on the black market in Germany as a designer drug analogue of methaqualone.
Animal studies of methylmethaqualone have shown it to produce convulsions at only slightly above the effective sedative dose, and anecdotal reports from human users have confirmed that it can have a pro-convulsive effect, which has potential to make this compound particularly hazardous if taken in excessive doses.